These results proved that this aminosterol can act by attenuating the PTP1B-induced HER2 signaling amplification in cancer cells [84], in agreement with previous studies that demonstrated a correlation between PTP1B overexpression and HER2/Erb2-positive breast cancer growth and invasiveness [46,47]. Here, ERBB2 is linked to breast carcinoma.